Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
amgen
3
×
biotech
life sciences
merck
3
×
national
national blog main
3
×
national top stories
new york blog main
alzheimer's disease
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cystic fibrosis
deals
detroit blog main
detroit top stories
diagnostics
eli lilly
europe blog main
gilead sciences
indiana blog main
indiana top stories
new york top stories
novartis
pfizer
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
What
acquisitions
biggest
bio
ceo
drug
roundup
adults
albert
allergan
approved
bourla
build
buy
class
company
company’s
crispr
daniel
debut
dyne’s
fda
future
gilead
imports
maker
maps
measured
medicines
microbiome
migraine
monday
moves
new
nod
openly
o’day
patients
pfizer
pfizer’s
pill
Language
unset
unknown
Current search:
abbvie
×
merck
×
amgen
×
" national blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More